M. TERESA
CEDENA ROMERO
Profesora asociada de Ciencias de la Salud
University of California, San Francisco
San Francisco, Estados UnidosPublicaciones en colaboración con investigadores/as de University of California, San Francisco (2)
2021
-
Making clinical decisions based on measurable residual disease improves the outcome in multiple myeloma
Journal of Hematology and Oncology
2020
-
The clinical significance of stringent complete response in multiple myeloma is surpassed by minimal residual disease measurements
PLoS ONE, Vol. 15, Núm. 8 August